Security Shot announced on August 11 the creation of a company BONK treasury, receiving $25 million in tokens by means of a strategic alliance with BONK founding contributors.
The Nasdaq-listed firm issued $35 million in convertible most popular shares as consideration for the allocation.
The association positions Security Shot amongst a rising cohort of public corporations adopting altcoin treasury methods past conventional Bitcoin holdings.
Latest company altcoin strikes embrace Bit Origin arranging $500 million for Dogecoin (DOGE) accumulation and SharpLink Gaming disclosing practically 600,000 ETH holdings.
Security Shot CEO Jarrett Boon said:
“This strategic partnership represents the primary stage of a much wider company evolution for our firm. By aligning with some of the thrilling ecosystems in digital property, we’re taking a daring first step.”
The partnership contains plans for expanded collaboration throughout the Solana ecosystem as Security Shot develops its digital asset infrastructure.
Technical infrastructure drives choice
Security Shot cited BONK’s Solana blockchain basis as a key issue within the treasury choice.
The corporate famous BONK’s high-speed, low-cost transaction capabilities present benefits over Ethereum-based rivals like Shiba Inu and Pepe, which they claimed face community congestion and elevated charges.
BONK held a market capitalization exceeding $2 billion as of press time, making it the fifth-largest memecoin.
The allocation follows Security Shot’s debt settlement and steadiness sheet optimization, which left the corporate with over $15 million in money reserves. The BONK tokens will function core treasury property inside Security Shot’s broader digital asset technique.
Broader altcoin treasury adoption
Company cryptocurrency treasury adoption has accelerated all through 2025, with corporations diversifying past Bitcoin (BTC) into specialised blockchain ecosystems.
XRP company treasury commitments are additionally elevated by means of corporations like Trident Digital, Webus Worldwide, and VivoPower Worldwide, demonstrating institutional urge for food for BTC alternate options.
Windtree Therapeutics secured agreements for as much as $200 million to determine BNB reserves, whereas Sonnet BioTherapeutics earmarked $583 million in HYPE tokens for balance-sheet deployment.
